


Professor at University of Southampton. Heart failure and device cardiologist. Cardiac MRI. Cardiomyopathy. Mad about squash.



New JACC: Heart Failure analysis of 4,342 patients with cardioMEMS ↑ PA diastolic by 1 mmHg → ~4% higher HF hospitalisation risk. >2 mmHg for 6m was associated with ~50% increased risk. How to translate this into effective, scalable HF care? @BSHeartFailure

The main caveat is that these are selected patients undergoing both CMR and angiography, so the should not be extrapolated to all patients with LV dysfunction.


No infarct-pattern LGE ≠ no coronary disease. New meta-analysis: 11% of patients with LV dysfunction and no infarct-pattern scar had significant CAD; 5% had high-risk anatomy. CMR identifies myocardial injury, not coronary anatomy. @pswoboda81


New defibrillation lead combining conduction-system pacing with ICD therapy. Promising technology, but will it improve outcomes over conventional CRT-D? Long-term lead performance and clinical benefit remain to be established.


CMR before AF ablation in LV dysfunction: 75% showed meaningful EF improvement. Non-responders had twice the LGE burden (6.6% vs 3.3%). Yet nearly half of responders also had LGE. Scar informs the probability of recovery. It shouldn't automatically exclude patients from ablation.


DECIDE-CRT: No clear survival benefit from adding a D to CRT in 3,965 patients with NICM. But CRT-P recipients were older and sicker. Propensity weighting cannot eliminate selection bias. We need randomised evidence. Can CMR scar identify who actually benefits? @ncurzen

SUBCUT-HF II: 4 extra days alive and out of hospital at 30 days with home SC furosemide. But HF readmissions were 14% vs 6%, and only ~4% of screened patients were enrolled at reporting sites. Promising model of care—but how scalable is the support needed? jacc.org/doi/10.1016/j.jacc.…

But the interesting signal is within the LBBAP group: confirmed LBB capture was associated with substantially better EF recovery than septal pacing.


CONDUCT-AF: LBB area pacing was non-inferior to BiV pacing for EF recovery after AV node ablation in HF with refractory AF. Shorter procedures too. Encouraging, but only 82 patients and 6 months' follow-up. Will longer-term clinical outcomes match?